Literature DB >> 24158803

Beyond standard molecular dynamics: investigating the molecular mechanisms of G protein-coupled receptors with enhanced molecular dynamics methods.

Jennifer M Johnston1, Marta Filizola.   

Abstract

The majority of biological processes mediated by G Protein-Coupled Receptors (GPCRs) take place on timescales that are not conveniently accessible to standard molecular dynamics (MD) approaches, notwithstanding the current availability of specialized parallel computer architectures, and efficient simulation algorithms. Enhanced MD-based methods have started to assume an important role in the study of the rugged energy landscape of GPCRs by providing mechanistic details of complex receptor processes such as ligand recognition, activation, and oligomerization. We provide here an overview of these methods in their most recent application to the field.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24158803      PMCID: PMC4074508          DOI: 10.1007/978-94-007-7423-0_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  127 in total

1.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.

Authors:  Richard A Friesner; Robert B Murphy; Matthew P Repasky; Leah L Frye; Jeremy R Greenwood; Thomas A Halgren; Paul C Sanschagrin; Daniel T Mainz
Journal:  J Med Chem       Date:  2006-10-19       Impact factor: 7.446

2.  From A to B in free energy space.

Authors:  Davide Branduardi; Francesco Luigi Gervasio; Michele Parrinello
Journal:  J Chem Phys       Date:  2007-02-07       Impact factor: 3.488

3.  The energy landscapes and motions of proteins.

Authors:  H Frauenfelder; S G Sligar; P G Wolynes
Journal:  Science       Date:  1991-12-13       Impact factor: 47.728

Review 4.  G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function.

Authors:  Graeme Milligan
Journal:  Br J Pharmacol       Date:  2009-03-20       Impact factor: 8.739

5.  Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications.

Authors:  L Toll; I P Berzetei-Gurske; W E Polgar; S R Brandt; I D Adapa; L Rodriguez; R W Schwartz; D Haggart; A O'Brien; A White; J M Kennedy; K Craymer; L Farrington; J S Auh
Journal:  NIDA Res Monogr       Date:  1998-03

6.  GPCR dimers fall apart.

Authors:  Nevin A Lambert
Journal:  Sci Signal       Date:  2010-03-30       Impact factor: 8.192

7.  Key residues defining the mu-opioid receptor binding pocket: a site-directed mutagenesis study.

Authors:  A Mansour; L P Taylor; J L Fine; R C Thompson; M T Hoversten; H I Mosberg; S J Watson; H Akil
Journal:  J Neurochem       Date:  1997-01       Impact factor: 5.372

8.  Generalized born model with a simple smoothing function.

Authors:  Wonpil Im; Michael S Lee; Charles L Brooks
Journal:  J Comput Chem       Date:  2003-11-15       Impact factor: 3.376

9.  Steered molecular dynamics simulations reveal the likelier dissociation pathway of imatinib from its targeting kinases c-Kit and Abl.

Authors:  Li-Jun Yang; Jun Zou; Huan-Zhang Xie; Lin-Li Li; Yu-Quan Wei; Sheng-Yong Yang
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

10.  A ligand channel through the G protein coupled receptor opsin.

Authors:  Peter W Hildebrand; Patrick Scheerer; Jung Hee Park; Hui-Woog Choe; Ronny Piechnick; Oliver P Ernst; Klaus Peter Hofmann; Martin Heck
Journal:  PLoS One       Date:  2009-02-05       Impact factor: 3.240

View more
  2 in total

Review 1.  Update on melatonin receptors: IUPHAR Review 20.

Authors:  Ralf Jockers; Philippe Delagrange; Margarita L Dubocovich; Regina P Markus; Nicolas Renault; Gianluca Tosini; Erika Cecon; Darius P Zlotos
Journal:  Br J Pharmacol       Date:  2016-08-08       Impact factor: 8.739

2.  Free energy calculations of the functional selectivity of 5-HT2B G protein-coupled receptor.

Authors:  Brandon L Peters; Jinxia Deng; Andrew L Ferguson
Journal:  PLoS One       Date:  2020-12-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.